Comoros vs Gambia: Cause of death, by non-communicable diseases, ages 0-4, male
Comoros
9.4%
in 2021
Gambia
9.4%
in 2021
Comoros rank
155th
Gambia rank
154th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Comoros
- Gambia
How they compare
Gambia currently reports 9.4% against 9.4% in Comoros, a difference of 0.0%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Gambia ahead.
Comoros ranks 155th and Gambia ranks 154th of 185 countries.
Across the 3 decades both report, Comoros averaged higher in 1 and Gambia in 2.
Head to head by decade
| Decade | Comoros | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.7% | 7.2% | 0.4% | Gambia |
| 2010s | 9.1% | 9.3% | 0.2% | Gambia |
| 2020s | 9.7% | 9.5% | 0.3% | Comoros |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Comoros or Gambia?
- Gambia, at 9.4% against 9.4% in Comoros as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Comoros and Gambia?
- 0.0%, with Gambia ahead.
- How many years of comparable data are there for Comoros and Gambia?
- 6 years are reported by both, from 2000 to 2021.
- How do Comoros and Gambia rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Comoros ranks 155th and Gambia ranks 154th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.